Back

Comorbid HIV and Cocaine Use Exacerbate Accelerated Brain Aging

Gu, H.; Salmeron, B. J.; Wang, D.; Lai, H.; Kuang, N.; Zheng, H.; Lai, S.; Yang, Y.

2026-02-09 neuroscience
10.64898/2026.02.06.704435 bioRxiv
Show abstract

BackgroundHIV and cocaine use (CU) each relate to cognitive deficits and brain abnormalities, yet their combined impact on brain aging remains unclear. This study examined how comorbid HIV and CU relate to brain aging and cognitive impairment. MethodsWe trained a morphometry-based brain-age model using harmonized Human Connectome Project-Aging data (HCP-A; n=725) with Gaussian Process Regression. The model was applied to an independent cohort with varying HIV/CU burden (HIV-/CU-, n=34; one disorder [HIV+/CU- or HIV-/CU+], n=72; HIV+/CU+, n=80). Brain age gap (BAG; predicted minus chronological age) was examined in relation to comorbidity burden and neurocognitive impairment (NCI; NIH Toolbox), adjusting for age, sex, education, depression, and image-quality indices. Analyses on SHapley Additive exPlanation (SHAP) values characterized network-wise feature-level contributions to brain age estimates. ResultsA dose-dependent effect of comorbidity burden on BAG was observed, with the HIV+/CU+ group showing the highest BAG. Greater BAG was associated with increased likelihood of NCI, and BAG partially mediated the relationship between comorbidity burden and NCI, with a stronger mediation effect in the two-disorder group than in the one-disorder group. Structural contributors to elevated BAG in the HIV/CU cohort included cortical thickness in the visual, ventral attention, and frontoparietal networks, and sulcal depth in the sensorimotor network. ConclusionComorbid HIV/CU is linked to accelerated structural brain aging. BAG may reflect brain-level alterations underlying the association between comorbid HIV/CU and cognitive impairment, and may help identify network-specific targets for intervention.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Translational Psychiatry
219 papers in training set
Top 0.3%
14.3%
2
Human Brain Mapping
295 papers in training set
Top 0.4%
12.5%
3
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.1%
12.3%
4
NeuroImage: Clinical
132 papers in training set
Top 0.4%
10.1%
5
Alzheimer's & Dementia
143 papers in training set
Top 0.9%
7.2%
50% of probability mass above
6
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
38 papers in training set
Top 0.5%
3.1%
7
Frontiers in Aging Neuroscience
67 papers in training set
Top 1%
2.7%
8
Imaging Neuroscience
242 papers in training set
Top 2%
2.1%
9
Molecular Psychiatry
242 papers in training set
Top 1%
2.1%
10
NeuroImage
813 papers in training set
Top 4%
1.9%
11
Frontiers in Psychiatry
83 papers in training set
Top 2%
1.7%
12
Nature Communications
4913 papers in training set
Top 55%
1.3%
13
eBioMedicine
130 papers in training set
Top 2%
1.2%
14
PLOS ONE
4510 papers in training set
Top 60%
1.2%
15
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.6%
1.2%
16
Scientific Reports
3102 papers in training set
Top 69%
0.9%
17
Neurobiology of Aging
95 papers in training set
Top 2%
0.9%
18
Communications Biology
886 papers in training set
Top 19%
0.9%
19
Biological Psychiatry
119 papers in training set
Top 2%
0.9%
20
eLife
5422 papers in training set
Top 55%
0.8%
21
Neuropsychopharmacology
134 papers in training set
Top 3%
0.7%
22
Neuroimage: Reports
22 papers in training set
Top 0.1%
0.7%
23
Cell Reports
1338 papers in training set
Top 34%
0.7%
24
eneuro
389 papers in training set
Top 10%
0.7%
25
PLOS Biology
408 papers in training set
Top 21%
0.7%
26
Alzheimer's Research & Therapy
52 papers in training set
Top 2%
0.7%
27
Biology of Sex Differences
29 papers in training set
Top 0.9%
0.6%
28
Aging Cell
144 papers in training set
Top 4%
0.6%
29
Aging
69 papers in training set
Top 4%
0.6%